Here, we provide a comprehensive list of all variants in addition to ATP13A2 that could serve as either drivers or phenotypic modifiers, ultimately leading to the presentation of a clinical picture that resembles juvenile-onset ALS. This evidence concerns the gene ATP13A2 and amyotrophic lateral sclerosis.